Serap Saygi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Serap Saygi has a total of 339 co-authors. Here are the top co-authors by number of shared publications:
- Fadime Irsel Tezer
Hacettepe University Faculty of Medicine
27 shared publications Abdurrahman Ciger
Institute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey
12 shared publicationsF. Irsel Tezer
Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
10 shared publicationsNejat Akalan
Hacettepe University, Faculty of Medicine, Department of Pathology, Neurology, Radiology, Neurosurgery
9 shared publicationsNese Dericioglu
Institute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey; Department of Neurology, Hacettepe University School of Medicine, Ankara, Turkey
9 shared publications- Nese Dericioglu
Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey
9 shared publications
Latest Publications
- Open Access
- 8 April 2026
- Published by Georg Thieme Verlag KG in International Journal of Epilepsy
- Vol. 12 (02) , 118-120
Phenytoin-Induced Orofacial Dyskinesia Mimicking Anti-NMDA Receptor Encephalitis: A Diagnostic Pitfall in Postoperative Epilepsy Patients
Postoperative epilepsy patients may present with new neurological symptoms that raise concern for autoimmune or infectious etiologies. In this case, a 25-year-old man with intellectual disability and left hippocampal sclerosis underwent left temporal lobectomy and hippocampectomy. After a seizure-free interval of 45 days, he developed multiple generalized tonic–clonic seizures in the setting of a postoperative subdural hematoma. Following hematoma evacuation, he received intravenous antiseizure therapy that was complicated by a medication dosing error. Shortly thereafter, he exhibited prominent involuntary orofacial movements, confusion, and persistent electrographic abnormalities. Neuroimaging showed new, mild bilateral posterior cortical enhancement, and electroencephalography (EEG) revealed lateralized periodic discharges. The constellation of movement disorder, seizures, and EEG changes raised concern for an autoimmune encephalitis, which can occur after epilepsy surgery and requires timely immunotherapy. However, cerebrospinal fluid analysis and a comprehensive autoimmune antibody panel were unremarkable. Over the subsequent 2 weeks, symptoms resolved in parallel with normalization of antiseizure drug levels, without the use of immunotherapy. This case underscores the importance of considering medication toxicity in the differential diagnosis of acute postoperative neurological syndromes. Recognition of drug-induced phenomena can prevent both misdiagnosis of autoimmune encephalitis and unnecessary treatment delays in patients who truly require immunotherapy.
- 8 April 2026
- Published by Georg Thieme Verlag KG in International Journal of Epilepsy
- Vol. 12 (02) , 118-120
Open AccessPhenytoin-Induced Orofacial Dyskinesia Mimicking Anti-NMDA Receptor Encephalitis: A Diagnostic Pitfall in Postoperative Epilepsy Patients
Postoperative epilepsy patients may present with new neurological symptoms that raise concern for autoimmune or infectious etiologies. In this case, a 25-year-old man with intellectual disability and left hippocampal sclerosis underwent left temporal lobectomy and hippocampectomy. After a seizure-free interval of 45 days, he developed multiple generalized tonic–clonic seizures in the setting of a postoperative subdural hematoma. Following hematoma evacuation, he received intravenous antiseizure therapy that was complicated by a medication dosing error. Shortly thereafter, he exhibited prominent involuntary orofacial movements, confusion, and persistent electrographic abnormalities. Neuroimaging showed new, mild bilateral posterior cortical enhancement, and electroencephalography (EEG) revealed lateralized periodic discharges. The constellation of movement disorder, seizures, and EEG changes raised concern for an autoimmune encephalitis, which can occur after epilepsy surgery and requires timely immunotherapy. However, cerebrospinal fluid analysis and a comprehensive autoimmune antibody panel were unremarkable. Over the subsequent 2 weeks, symptoms resolved in parallel with normalization of antiseizure drug levels, without the use of immunotherapy. This case underscores the importance of considering medication toxicity in the differential diagnosis of acute postoperative neurological syndromes. Recognition of drug-induced phenomena can prevent both misdiagnosis of autoimmune encephalitis and unnecessary treatment delays in patients who truly require immunotherapy.
- Open Access
- 17 December 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (12) , e70971
Prodromal Sleep Disturbances and Polysomnographic Findings in Patients With Creutzfeldt–Jakob Disease
Purpose: Prion diseases are fatal neurodegenerative disorders of the central nervous system. Sporadic Creutzfeldt–Jakob disease (sCJD) is the most encountered form of the disease. The mean survival time is less than a year after diagnosis. Sleep problems are common in CJD. However, only a few studies revealed sleep pathology of CJD. Method: Between 2013 and 2023, patients diagnosed with probable CJD who had video electroencephalography (EEG) and polysomnography (PSG) studies were evaluated. Detailed examination of the first and last EEGs (if any) was based on background activity, slow wave paroxysms, epileptiform discharges, and additional findings. Macro‐ and microstructure of sleep and sleep disturbances were evaluated with PSG studies. Results: Seven patients (two females, five males) at the mean age of 60 years were analyzed. Gait disturbances, difficulty in speech, and visual problems were common in addition to progressive cognitive impairment. Neurological examination revealed ataxia, dysarthria, myoclonus and/or aphasia, and loss of vision. Typical 1 Hz generalized periodic discharges and slow wave activity on the background were encountered in the advanced stage of the disease. Sleep‐related problems were reported by three patients (42.8%); however, when we questioned carefully, we realized all patients had sleep disturbances such as simple or complex movements during sleep, sleep vocalizations, insomnia, and daytime sleepiness simultaneously with the main symptom. During PSG recording, sleep‐related apnea and insomnia were frequently reported. Interestingly, one patient had an initial de novo finding of Cheyne–Stokes apnea. Conclusion: Sleep problems such as insomnia or apnea could be the first sign of CJD. It should be carefully questioned of every patient and caregiver. PSG may help to specify prognostic and clinical differences.
- 17 December 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (12) , e70971
Open AccessProdromal Sleep Disturbances and Polysomnographic Findings in Patients With Creutzfeldt–Jakob Disease
Purpose: Prion diseases are fatal neurodegenerative disorders of the central nervous system. Sporadic Creutzfeldt–Jakob disease (sCJD) is the most encountered form of the disease. The mean survival time is less than a year after diagnosis. Sleep problems are common in CJD. However, only a few studies revealed sleep pathology of CJD. Method: Between 2013 and 2023, patients diagnosed with probable CJD who had video electroencephalography (EEG) and polysomnography (PSG) studies were evaluated. Detailed examination of the first and last EEGs (if any) was based on background activity, slow wave paroxysms, epileptiform discharges, and additional findings. Macro‐ and microstructure of sleep and sleep disturbances were evaluated with PSG studies. Results: Seven patients (two females, five males) at the mean age of 60 years were analyzed. Gait disturbances, difficulty in speech, and visual problems were common in addition to progressive cognitive impairment. Neurological examination revealed ataxia, dysarthria, myoclonus and/or aphasia, and loss of vision. Typical 1 Hz generalized periodic discharges and slow wave activity on the background were encountered in the advanced stage of the disease. Sleep‐related problems were reported by three patients (42.8%); however, when we questioned carefully, we realized all patients had sleep disturbances such as simple or complex movements during sleep, sleep vocalizations, insomnia, and daytime sleepiness simultaneously with the main symptom. During PSG recording, sleep‐related apnea and insomnia were frequently reported. Interestingly, one patient had an initial de novo finding of Cheyne–Stokes apnea. Conclusion: Sleep problems such as insomnia or apnea could be the first sign of CJD. It should be carefully questioned of every patient and caregiver. PSG may help to specify prognostic and clinical differences.
- 15 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110592
Psychogenic non-epileptic seizures in patients undergoing epilepsy surgery: experience from a tertiary referral center
- 15 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110592
Psychogenic non-epileptic seizures in patients undergoing epilepsy surgery: experience from a tertiary referral center
- 22 August 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 147, 109385
Ictal crying in epileptic seizures and psychogenic nonepileptic seizures: What are the hints to differentiate them?
- 22 August 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 147, 109385
Ictal crying in epileptic seizures and psychogenic nonepileptic seizures: What are the hints to differentiate them?
Birth outcomes in pregnant women with epilepsy: A Nationwide multicenter study from Türkiye
Objective: The present study was aimed at investigating the effects of anti‐seizure medications (ASMs), patient demographic characteristics, and the seizure type and frequency on the development of congenital malformations (CMs) in the infants of pregnant women with epilepsy (PWWE).Methods: PWWE followed up at the neurology outpatient clinic of 21 centers between 2014 and 2019 were included in this prospective study. The follow‐up of PWWE was conducted using structured, general pregnant follow‐up forms prepared by the Pregnancy and Epilepsy Study Committee. The newborns were examined by a neonatologist after delivery and at 1 and 3 months postpartum.Results: Of the infants of 759 PWWE, 7.2% had CMs, with 5.6% having major CMs. Polytherapy, monotherapy, and no medications were received by 168 (22.1%), 548 (72.2 %), and 43 (5.7 %) patients, respectively. CMs were detected at an incidence of 2.3% in infants of PWWE who did not receive medication, 5.7% in infants of PWWE who received monotherapy, and 13.7% in infants of PWWE who received polytherapy. The risk of malformation was 2.31‐fold (95% confidence interval (CI): 1.48–4.61, p < .001) higher in infants of PWWE who received polytherapy. Levetiracetam was the most frequently used seizure medication as monotherapy, with the highest incidence of CMs occurring with valproic acid (VPA) use (8.5%) and the lowest with lamotrigine use (2.1%). The incidence of CMs was 5% at a carbamazepine dose p = .041) in infants of PWWE receiving high‐dose ASMs.Significance: Birth outcomes of PWWE receiving and not receiving ASMs were evaluated. The risk of CMs occurrence was higher, particularly in infants of PWWE using VPA and receiving polytherapy. The incidence of CMs was found to be lower in infants of PWWE receiving lamotrigine.
Birth outcomes in pregnant women with epilepsy: A Nationwide multicenter study from Türkiye
Objective: The present study was aimed at investigating the effects of anti‐seizure medications (ASMs), patient demographic characteristics, and the seizure type and frequency on the development of congenital malformations (CMs) in the infants of pregnant women with epilepsy (PWWE).Methods: PWWE followed up at the neurology outpatient clinic of 21 centers between 2014 and 2019 were included in this prospective study. The follow‐up of PWWE was conducted using structured, general pregnant follow‐up forms prepared by the Pregnancy and Epilepsy Study Committee. The newborns were examined by a neonatologist after delivery and at 1 and 3 months postpartum.Results: Of the infants of 759 PWWE, 7.2% had CMs, with 5.6% having major CMs. Polytherapy, monotherapy, and no medications were received by 168 (22.1%), 548 (72.2 %), and 43 (5.7 %) patients, respectively. CMs were detected at an incidence of 2.3% in infants of PWWE who did not receive medication, 5.7% in infants of PWWE who received monotherapy, and 13.7% in infants of PWWE who received polytherapy. The risk of malformation was 2.31‐fold (95% confidence interval (CI): 1.48–4.61, p < .001) higher in infants of PWWE who received polytherapy. Levetiracetam was the most frequently used seizure medication as monotherapy, with the highest incidence of CMs occurring with valproic acid (VPA) use (8.5%) and the lowest with lamotrigine use (2.1%). The incidence of CMs was 5% at a carbamazepine dose p = .041) in infants of PWWE receiving high‐dose ASMs.Significance: Birth outcomes of PWWE receiving and not receiving ASMs were evaluated. The risk of CMs occurrence was higher, particularly in infants of PWWE using VPA and receiving polytherapy. The incidence of CMs was found to be lower in infants of PWWE receiving lamotrigine.
- 1 December 2022
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (4) , 1351-1360
Sleep disorders and polysomnography findings in patients with autoimmune encephalitis
- 1 December 2022
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (4) , 1351-1360
Sleep disorders and polysomnography findings in patients with autoimmune encephalitis
- 26 June 2022
- Published by Elsevier in Epilepsy Research
- Vol. 184, 106972
Relation between orexin A and epileptic seizures
- 26 June 2022
- Published by Elsevier in Epilepsy Research
- Vol. 184, 106972
Relation between orexin A and epileptic seizures
- 16 June 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 100, 30-35
Changes of oxygen saturation in patients with pure temporal lobe epilepsy
- 16 June 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 100, 30-35
Changes of oxygen saturation in patients with pure temporal lobe epilepsy
- 1 February 2022
- Published by Elsevier in Epilepsy Research
- Vol. 180, 106545
A response: Aphasic epileptic state as a manifestation of a stroke-like episode in MELAS
- 1 February 2022
- Published by Elsevier in Epilepsy Research
- Vol. 180, 106545
A response: Aphasic epileptic state as a manifestation of a stroke-like episode in MELAS